From Operator to Asset Architect

For over 25 years, I’ve sat across the table from business owners, performing valuations for hundreds of companies. In that time, I have observed a recurring, often painful distinction: There is a massive difference between running a profitable business and building a transferable asset.

Most owners are brilliant operators. They know how to sell, how to build, and how to grind. But very few are Asset Architects.

In the lower middle market, valuation is too often treated as a "rearview mirror" exercise that’s done once a year for tax compliance. That is a missed opportunity. Valuation should be a dynamic, forward-looking strategy. My mission with this newsletter is to provide the intelligence necessary to shift your focus from daily operations to systematic enterprise value.

The Reality: The "Multiple Gap"

To understand why "Asset Architecture" matters, we must look at how the current market prices different business designs. As of December 31, 2025, we see a stark widening in the valuation gap among businesses of different quality.

Industry Group

Median ROIC

Revenue Growth

EBITDA Multiples

Application Software

7.5%

10.6%

13x - 28x

Healthcare Services

5.8%

11.8%

9x - 16x

Industrial Machinery

6.2%

2.6%

7x - 13x

Cargo Transportation

3.7%

-5.3%

7x - 13x

The Insight: Why does a dollar of profit in a software company command a multiple two to three times richer than the same dollar in a trucking company? It isn't industry hype. Notice that Healthcare Services posts the strongest revenue growth at 11.8%, yet trades at a discount to Application Software. Growth alone doesn't explain it. The market pays its richest premiums where capital efficiency and predictability travel together. Software converts each dollar of invested capital into durable, recurring profit, while Cargo Transportation and Industrial Machinery sit at the bottom of the range, valued on cyclical, capital-intensive earnings rather than recurring ones. The market rewards Efficiency of Capital and Predictability.

The Multiples Myth: What the Market is Actually Buying

There is a common debate in corporate finance. Experts at firms like McKinsey often argue that "multiples" are a distraction. They contend that a multiple is merely an output of two fundamental forces: Growth and Return on Invested Capital (ROIC).

From an academic standpoint, they are absolutely right. A multiple is just a shorthand. If your business can grow without needing to buy a new factory or double your headcount for every new dollar of revenue—meaning you have a high ROIC—the math dictates that your multiple should be higher.

However, for the private business owner, the Multiple is the primary language of the market. It’s how your life's work is priced by private equity groups and strategic buyers.

The secret to Asset Architecture is understanding the fundamental "Why" (ROIC) so you can intentionally manipulate the "What" (The Multiple).

Why ROIC is the "Quality" Meter

Imagine two companies, both earning $1M in profit.

  • Company A needs to reinvest $500k every year into new equipment and inventory just to maintain that profit.

  • Company B needs to reinvest only $50k to keep the same $1M flowing.

McKinsey & Company’s research shows that the market will always value Company B more highly. Why? Because Company B has "high-quality" cash. They can use their excess funds to grow, while Company A is stuck in a cycle of heavy maintenance.

When you hear a buyer talk about "Risk" or "Scalability," what they are really talking about is your ROIC. They are asking: "How much does it cost me to buy your next dollar of profit?"

Physiology vs. Autopsy: A New Perspective

Most owners treat valuation like an autopsy—a post-mortem performed when the "life" of their ownership is ending. But true Asset Architects view it as physiology.

In the medical world, we don't just look at height and weight (Revenue and EBITDA). We look at systems. We view Cash Flow as the cardiovascular system, Growth as the musculoskeletal system, and Risk as the immune system—all coordinated by the central nervous system of "The Who" (Leadership, Culture, and Execution).

If you aren't tracking the levers that expand your multiple, you are running a race without knowing where the finish line is. Through this newsletter, I'm on a mission to bridge the gap between institutional-grade finance theory and the unique, often messy realities of the lower middle market.

Looking Ahead: Issue #2

Next month, we move from the "What" to the "How."

I'll introduce the Value Creation Flywheel™—a proprietary framework that maps your company's health across its vital "organ systems": Cash Flow, Growth, and Risk. We'll explore how the bidirectional flow of energy between these systems—the Metabolic Gears of Deploy, Leverage, and De-Risk—is the secret to moving your business from a standard industry multiple to a premium one. And we'll meet the Central Nervous System—the leadership, culture, and execution that coordinate the whole organism.

Value creation is not an accident. It is an architecture.

Best,
Jeremy
Principal, Sawtooth Value Advisory

Keep Reading